In the following table, adverse reactions have been grouped on the basis of "Internationally agreed Order of Importance" System Organ Class (SOC) MedDRA Classification. In each SOC, undesirable effects were classified according to their occurrence frequency. In each frequency class the undesirable effects are reported according to a decreasing order of severity.
Within the system organ classes, adverse reactions are listed under headings of frequency (number of patients expected to experience the reaction), using the following categories: Very common (≥1/10); Common (≥1/100 to <1/10); Uncommon (≥1/1,000 to <1/100); Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). (See table.)

Cases of hypercholesterolaemia have been reported, but a causal link has not been demonstrated.
View ADR Reporting Link